Cargando…

Kuntai Capsule plus Hormone Therapy vs. Hormone Therapy Alone in Patients with Premature Ovarian Failure: A Systematic Review and Meta-Analysis

The aim of this study was to evaluate the efficacy and safety of Kuntai capsules (KTC) plus hormone therapy (HT) compared to HT alone for the treatment of premature ovarian failure (POF). Databases including PubMed, MEDLINE, Web of Science, China National Knowledge Infrastructure (CNKI), the Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Weiping, Nguyen, Truong-Nam, Tran Thi, Thu-Van, Zhou, Shaohu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617870/ https://www.ncbi.nlm.nih.gov/pubmed/31346337 http://dx.doi.org/10.1155/2019/2085804

Ejemplares similares

Corrigendum to “Kuntai Capsule plus Hormone Therapy vs. Hormone Therapy Alone in Patients with Premature Ovarian Failure: A Systematic Review and Meta-Analysis”
por: Liu, Weiping, et al.
Publicado: (2021)

The effect of Kuntai capsule on ovarian function in cisplatin-induced premature ovarian insufficiency rats
por: Luo, Suiyu, et al.
Publicado: (2023)

Effectiveness of Cotreatment with Kuntai Capsule and Climen for Premature Ovarian Failure: A Meta-Analysis
por: Ma, Qianwen, et al.
Publicado: (2020)

Kuntai Capsule Combined With Letrozole on Gonadal Hormone Levels and Ovarian Function in Patients With PCOS: A Systematic Review and Meta-Analysis
por: Tang, Xing, et al.
Publicado: (2021)

Clinical observation of Kuntai capsule combined with Fenmotong in treatment of decline of ovarian reserve function
por: Lin, Xin-Miao, et al.
Publicado: (2021)

Identification of the active ingredients and pharmacological effects of Kuntai capsules in the treatment of primary ovarian insufficiency: A review
por: Liu, Feng-Xia, et al.
Publicado: (2023)

Kuntai Capsule Inhibited Endometriosis via Inducing Apoptosis in a Rat Model
por: Zhong, Ruihua, et al.
Publicado: (2016)

Efficacy and Safety Investigation of Kuntai Capsule for the Add-back Therapy of Gonadotropin Releasing Hormone Agonist Administration to Endometriosis Patients: A Randomized, Double-blind, Blank- and Tibolone-controlled Study
por: Chen, Ji-Ming, et al.
Publicado: (2015)

Cardiovascular Risk Factors in Premature Ovarian Insufficiency using Hormonal Therapy
por: Rezende, Gabriela Pravatta, et al.
Publicado: (2023)

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial
por: James, Nicholas D, et al.
Publicado: (2012)

Premature ovarian insufficiency – hormone replacement therapy and management of long-term consequences
por: Machura, Paulina, et al.
Publicado: (2018)

Follicular development during hormone replacement therapy in patients with premature ovarian insufficiency
por: Sato, Takuma, et al.
Publicado: (2021)

The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis
por: Zhang, Shuzhen, et al.
Publicado: (2021)

Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics
por: Li, Xiushen, et al.
Publicado: (2022)

Impact of Hormonal Replacement Therapy on Bone Mineral Density in Premature Ovarian Insufficiency Patients
por: Podfigurna, Agnieszka, et al.
Publicado: (2020)

Kuntai capsules improve glucolipid metabolism in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
por: Liang, Ruining, et al.
Publicado: (2019)

A case report of spontaneous pregnancy during hormonal replacement therapy for premature ovarian failure
por: Akbari Asbagh, Firoozeh, et al.
Publicado: (2011)

Poor Compliance to Hormone Therapy and Decreased Bone Mineral Density in Women with Premature Ovarian Insufficiency
por: Bachelot, Anne, et al.
Publicado: (2016)

Hormone Replacement Therapy Reverses Gut Microbiome and Serum Metabolome Alterations in Premature Ovarian Insufficiency
por: Jiang, Lingling, et al.
Publicado: (2021)

Menopausal hormone therapy and ovarian cancer
por: Baber, Rod
Publicado: (2015)

Comparative Overall Survival of CDK4/6 Inhibitors Plus Endocrine Therapy vs. Endocrine Therapy Alone for Hormone receptor-positive, HER2-negative metastatic breast cancer
por: Lin, Mingxi, et al.
Publicado: (2020)

Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer: The MANTA Phase 2 Randomized Clinical Trial
por: Schmid, Peter, et al.
Publicado: (2019)

Chinese patent medicines combined with hormone replacement therapy for premature ovarian failure: A Bayesian network meta-analysis
por: Zhong, Han-Zhi, et al.
Publicado: (2022)

Hormone replacement therapy and risk of epithelial ovarian cancer
por: Purdie, D M, et al.
Publicado: (1999)

The role of hormonal factors and endocrine therapy in ovarian cancer
por: Serkies, Krystyna, et al.
Publicado: (2013)

Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications
por: Li, Hongyi, et al.
Publicado: (2021)

Diminished Ovarian Reserve Predisposes to Premature Luteinizing Hormone Surges in Gonadotropin-Releasing Hormone Antagonist Cycles in In vitro Fertilization
por: Kochhar, Puneet Kaur, et al.
Publicado: (2020)

TRADITIONAL CHINESE MEDICINE COMBINED WITH HORMONE THERAPY TO TREAT PREMATURE OVARIAN FAILURE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
por: Kou, Mei-Jing, et al.
Publicado: (2016)

Hormone Therapy
por: Howell, A.
Publicado: (1982)

Postoperative Hormone Replacement Therapy and Survival in Women with Ovarian Cancer
por: Ji, Eunjeong, et al.
Publicado: (2022)

Effect of thyroid hormone replacement therapy on ovarian volume and androgen hormones in patients with untreated primary hypothyroidism
por: Muderris, Iptisam Ipek, et al.
Publicado: (2011)

Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency
por: Cai, Yan, et al.
Publicado: (2022)

INDIVIDUALIZATION OF CUSTOM COMPOUNDED HORMONE THERAPY IN A PATIENT WITH CHEMOTHERAPY INDUCED PREMATURE OVARIAN INSUFFICIENCY AND IMPAIRED LIVER FUNCTION – CASE REPORT
por: Franić, Damir, et al.
Publicado: (2019)

Thyroid Hormones and Functional Ovarian Reserve: Systemic vs. Peripheral Dysfunctions
por: Colella, Marco, et al.
Publicado: (2020)

Premature ovarian insufficiency: A hormonal treatment approach: Number 2 - August 2020
por: Benetti-Pinto, Cristina Laguna, et al.
Publicado: (2020)

The Hormone Therapy and Constipation
Publicado: (1914)

Retracted: Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency
por: International, BioMed Research
Publicado: (2023)

Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy
por: Pickar, James H., et al.
Publicado: (2015)

OR29-03 The Effects of Hormone Therapy on Premature Ovarian Failure Following Allogenic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
por: Ha, Jeonghoon, et al.
Publicado: (2020)

MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome
por: Legro, Richard, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9v9icvtr6qlbld35mrhjd5131n